
How covid-19 could become as mild as a common cold
21 January 2021
As the new coronavirus evolves, it could follow the same path as other coronaviruses we live with already, becoming far less deadly in the future

21 January 2021
As the new coronavirus evolves, it could follow the same path as other coronaviruses we live with already, becoming far less deadly in the future

20 January 2021
We are still working out what new coronavirus variants will mean for us. As we adapt, there is one thing we know for certain: the only way to stop the virus evolving is to stop it from spreading

20 January 2021
Big tech firms have enabled the US’s current mess – the time has come for them to acknowledge that they are key to our political process and repair the things they have broken, writes Annalee Newitz

20 January 2021
More transmissible coronavirus variants, coupled with questions about whether the vaccines prevent transmission, means it might be impossible to wipe out covid-19

20 January 2021
The highly infectious B.1.1.7 coronavirus variant from the UK has now been reported in more than 50 countries, placing new urgency on the race to vaccinate the vulnerable

20 January 2021
New versions of coronavirus that spread faster and might evade the immune system are causing fears about vaccine efficacy and a rise in covid-19 deaths. Here’s what you need to know

20 January 2021
The World Health Organization has begun its investigation to try to determine the source of the coronavirus, but there have already been clashes between the US and China over access to people and evidence

20 January 2021
Life as we know it depends on water, and not just as a liquid for DNA and protein to float around in – it is more actively involved in life’s chemical reactions than we previously realised

19 January 2021
It looks like some of the new coronavirus variants can evade parts of our immune response, but it's not yet clear if we need to update the vaccines

15 January 2021
The race to vaccinate as many people as possible against covid-19 is under way, but unless countries track who receives the vaccine we won’t be able to ensure the benefits are spread equitably, says Layal Liverpool